• • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Do-Youn Oh, MD, PhD

    Peer

  5

  

  RestartResume

  RestartResume

  Biliary Tract Carcinoma: Are We at the Point of Change?

• • 

    

    Leora Horn, MD, MSc

    Peer

  3

  

  RestartResume

  RestartResume

  Immunotherapy: Changing Patient Outcomes in SCLC

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Jyoti Patel, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  2

  

  RestartResume

  RestartResume

  Practical Considerations on the Use of Immune Checkpoint Inhibitors & Chemoth...

• • 

    

    Alfredo L. Falcone, MD

    Peer

  • 

    

    Sebastian Stintzing, MD

    Peer

  • 

    

    Tianshu Liu, MD

    Peer

  3

  

  RestartResume

  RestartResume

  Considerações Clínicas na Sequenciação do Tratamento do CCRM

• • 

    

    Alfredo L. Falcone, MD

    Peer

  • 

    

    Sebastian Stintzing, MD

    Peer

  • 

    

    Tianshu Liu, MD

    Peer

  3

  

  RestartResume

  RestartResume

  Aspectos clínicos en la secuenciación del tratamiento para el cáncer colorrec...

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Joshua Bauml, MD

    Peer

  2

  

  RestartResume

  RestartResume

  Distilling Modern Medical Approaches in Advanced NSCLC: Precision, Performanc...

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  15

  

  RestartResume

  RestartResume

  Melhorar a Prática Clínica na Gestão do mCRC: Ênfase no Lado do Tumor

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  15

  

  RestartResume

  RestartResume

  Mejorar la práctica clínica en el tratamiento del CCRm: énfasis en la lateral...

Featured

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  17

  

  RestartResume

  RestartResume

  Improving Clinical Practice in Management of mCRC: A Focus on Tumor Sidedness

• • 

    

    Timothy A. McCarthy, MD

    Peer

  13

  

  RestartResume

  RestartResume

  Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC

• • 

    

    Edward S. Kim, MD

    Peer

  3

  

  RestartResume

  RestartResume

  The Value of Multidisciplinary Teams in NSCLC Care Plans

• • 

    

    Alfredo L. Falcone, MD

    Peer

  • 

    

    Sebastian Stintzing, MD

    Peer

  • 

    

    Tianshu Liu, MD

    Peer

  6

  

  RestartResume

  RestartResume

  Clinical Considerations in Treatment Sequencing for mCRC

• 4

  

  RestartResume

  RestartResume

  Best Practices for Existing Epidermal Growth Factor Receptor (EGFR) Inhibitor...
• 2

  

  RestartResume

  RestartResume

  Management of Recurrent Squamous Cell Carcinoma of the Head & Neck

• • 

    

    Tanguy Seiwert, MD

    Peer

  4

  

  RestartResume

  RestartResume

  Current Recommendations: HPV Tumors in Head & Neck Cancers
• 4

  

  RestartResume

  RestartResume

  Recent Breakthroughs in Head and Neck Cancer
• 3

  

  RestartResume

  RestartResume

  Colorectal Cancer Physician Resources
• 4

  

  RestartResume

  RestartResume

  Head and Neck Physician Resources

• • 

    

    Makoto Tahara

    Peer

  6

  

  RestartResume

  RestartResume

  Patient Case Study: Role of Cetuximab in treatment of SCC Head and Neck Cance...
• 10

  

  RestartResume

  RestartResume

  Interview with Makoto Tahara, MD, PhD | Japan